Back | Next |
home / stock / sonn / sonn message board
Subject | By | Source | When |
---|---|---|---|
Sonnet BioTherapeutics Announces Presentations at the 2023 Cytokine-Based | crazy horse 0 | investorshub | 06/26/2023 11:48:41 PM |
As did I! GLTA | SecondLife | investorshub | 06/26/2023 8:46:43 PM |
added to my $SONN today! | Earlofsandwich | investorshub | 06/26/2023 8:33:10 PM |
Somethings up, that was a good bit of | limer814 | investorshub | 06/26/2023 4:29:10 PM |
Missed that dip :( | limer814 | investorshub | 06/26/2023 1:58:51 PM |
Tine to fly! | Tiger Money | investorshub | 06/26/2023 1:36:02 PM |
Good Morning $SONN Rise and shine everybody..it's Monday!!! | Carjockey2 | investorshub | 06/26/2023 1:25:10 PM |
Video $SONN | crazy horse 0 | investorshub | 06/24/2023 10:58:23 PM |
HOD .83~~~~~Looking good for $1+ next week imo..............Have | Golden Cross | investorshub | 06/23/2023 10:56:33 PM |
got the machines working on this sonn they | Earlofsandwich | investorshub | 06/23/2023 8:06:29 PM |
Not today.. $SONN | Carjockey2 | investorshub | 06/23/2023 7:41:43 PM |
When Lambo ???? $SONN | Carjockey2 | investorshub | 06/23/2023 5:03:26 PM |
Market Cap | lecorb | investorshub | 04/24/2023 4:27:55 PM |
how many shares out here | frans | investorshub | 04/20/2023 12:45:07 PM |
THX https://investorshub.advfn.com/boards/read msg.aspx?message id=171730525&tx | TheFinalCD | investorshub | 04/20/2023 11:41:38 AM |
$SONN getting recognized. mb | Mt. Blanc | investorshub | 04/20/2023 11:22:57 AM |
NEWS Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 | subslover | investorshub | 04/20/2023 10:01:54 AM |
$SONN 5.4 million in volume PM. Is the | reena969 | investorshub | 04/20/2023 9:16:58 AM |
Agreed I loaded son in the $ before | govprs | investorshub | 01/20/2023 2:40:26 PM |
Still good things happening so I'll be loading | BooDog | investorshub | 01/20/2023 2:09:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Sonnet BioTherapeutics Holdings Inc. Company Name:
SONN Stock Symbol:
NASDAQ Market:
Published Phase 1 data of SON-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteers Announced early safety data from the company's Phase 1b/2a clinical trial of SON-080 in patients with chemotherapy-induced peri...
Minneapolis, Minnesota--(Newsfile Corp. - May 3, 2024) - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs, will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The P...